나고야의정서 이행에 따른 새로운 유전자원 접근 이익공유 체계의 이해와 미생물 연구자의 대응방안
Understanding the Access and Benefit-Sharing of Genetic Resources for Microbiology Researchers
1
조회
0
다운로드
4
인용
0
참고문헌
키워드
초록
최근 생명공학 R&D의 필수 재료인 유전자원에 대한 취득과 그 이용을 규제하는 국제 규범, 즉 나고야의정서가 등장하면서 관련 분야 연구자에게 상당한 불편과 부담이 우려되고 있다. 나고야의정서가 발효함에 따라 그 동안 인류공동유산으로서 마치 공공재처럼 모든 국가가 자유롭게 사용해왔던 유전자원에 대하여 자원 보유국의 배타적 소유권이 인정되면서 자원의 취득과 이용에 대한 각국의 법적 규제가 도입되고 있다. 특히 유전자원의 해외의존도가 높은 우리나라는 보다 체계적인 대응을 해야 할 필요성이 있다. 이 글은 연구자를 포함한 국내외 유전자원 이용자의 나고야의정서에대한 인식 제고를 위하여, 먼저 의정서의 주요 핵심내용을분석하고 해외 유전자원 이용을 위한 접근, 취득 및 이익공유의 전체적인 구조와 흐름을 제시함으로써 향후 적절한 대응에 도움이 될 수 있도록 구성·기술하였다. 나고야의정서에 적절하게 대처하기 위해서는 연구자 본인의 노력과 국가적인 차원에서의 지원이 동시에 필요하다. 우선 연구자는 나고야의정서 체제에서의 연구활동 진행에 관한 전체적인 틀과 각 단계별 구체적인 대응에 관한 이해를반드시 해야 한다. 이를 토대로 유전자원 접근단계부터 이로인해 발생한 이익의 공유단계까지 제공국의 ABS절차에 적절하게 대응해야 한다. 이렇게 볼 때 나고야의정서로 인해과거 대비 연구활동에 일정부분 제한이 가해지고 연구 외적인 부담이 가중되었다고 할 수 있다. 하지만 전 세계적으로유전자원에 대한 국가의 주권을 인정하는 시류가 한시적이라고 보기 힘든 상황임은 분명하다. 나고야의정서 체제를 중심으로 자국의 유전자원에 대한 주권적 권리를 지키고자 하는 자원부국의 기조가 더 강해질 것으로 예상된다. 따라서국내 연구자도 관련 피해를 최소화하기 위한 대비를 보다 확실히 해야 할 것이다.
Abstract
Following enforcement of the Nagoya Protocol (NP), in which the sovereign rights to genetic resources of countries are recognized, new legal obligations regarding access and benefit-sharing (ABS) that did not exist before have now been imposed on researchers. To implement the NP, many countries are introducing new procedures and regulations when a researcher wants to obtain genetic resources for commercial or noncommercial uses. It is therefore expected that resource-rich countries will adopt strong regulations to protect their genetic resources. In this regard, Korean microbiologists will need to respond to these changes to minimize the potential damages caused by the ABS. This paper reviews the key contents of the NP to raise its awareness among scientific researchers and further presents specific measures to meet the ABS obligations accordingly. For example, Korean researchers, in principle, do not need to acquire Prior Informed Consents (PICs) when they access Korean microbial resources for both commercial or research purposes. Nevertheless, when a foreign culture collection agency such as DSMZ requests a confirmation of compliance with the NP to deposit genetic resources, Korean researchers can also apply for a PIC with the Korean government as an exception. By referring to this article, microbiologists will be able to conduct their research in compliance with the NP while respecting the legal ABS obligations of each resource-providing country.
참고문헌 (37)
- Lau SK, "Metabolomic profiling of plasma from patients with tuberculosis by use of untargeted mass spectrometry reveals novel biomarkers for diagnosis", J. Clin. Microbiol, 53, pp.3750~3759 (2015)
- Zumla A, "Viewpoint : Scientific dogmas, paradoxes and mysteries of latent Mycobacterium tuberculosis infection", Trop. Med. Int. Health, 16, pp.79~83 (2011)
- Nema V, "Tuberculosis diagnostics : Challenges and opportunities", Lung India, 29, pp.259~266 (2012)
- Gautam US, "In vivo inhibition of tryptophan catabolism reorganizes the tuberculoma and augments immune-mediated control of Mycobacterium tuberculosis", Proc. Natl. Acad. Sci. USA, 115, pp.E62~E71 (2018)
- Lange C, "Management of patients with multidrugresistant", extensively drug-resistant tuberculosis in Europe : a TBNET consensus statement, 2014, pp.44, 23~63
- Caulfield AJ, "Diagnosis of active tuberculosis disease : From microscopy to molecular techniques", J. Clin. Tuberc. Other Mycobact. Dis, 4, pp.33~43 (2016)
- Moore DF, "Detection and identification of Mycobacterium tuberculosis directly from sputum sediments by ligase chain reaction", J. Clin. Microbiol, 36, pp.1028~1031 (1998)
- Odubanjo MO, "The microbiological diagnosis of tuberculosis in a resource-limited setting : is acidfast bacilli microscopy alone sufficient? Ann", Ib. Postgrad. Med, 9, pp.24~29 (2011)
- Huang H, "Plasma metabolites xanthine, 4-pyridoxate, and d-glutamic acid as novel potential biomarkers for pulmonary tuberculosis", Clin. Chim. Acta, 498, pp.135~142 (2019)
- Gupta R, "Tuberculosis as a major global health problem in the 21st century : A WHO perspective", Semin. Respir. Crit. Care Med, 25, pp.245~253 (2004)
- Harries AD, "Challenges and progress with diagnosing pulmonary tuberculosis in low-and middle-income countries", Diagnostics(Basel), 8, pp.78~ (2018)
- Zhang A, "Metabolomics for biomarker discovery : Moving to the clinic", Biomed. Res. Int, 2015, pp.354671~ (2015)
- Shah SH, "Metabolomic profiling for the identification of novel biomarkers and mechanisms related to common cardiovascular diseases : form and function", Circulation, 126, pp.1110~1120 (2012)
- Wang X, "Urine metabolomics analysis for biomarker discovery and detection of jaundice syndrome in patients with liver disease", Mol. Cell. Proteomics, 11, pp.370~380 (2012)
- Engle S, "Unboxing cluster heatmaps", BMC Bioinformatics, 18, pp.63~ (2017)
- Adu-Gyamfi CG, "Diagnostic accuracy of plasma kynurenine", tryptophan ratio, measured by enzyme-linked immunosorbent assay, for pulmonary tuberculosis, 2020, pp.99, 441~448
- Burns-Huang K, "Mycobacterium tuberculosis cysteine biosynthesis genes mec+-cysO-cysM confer resistance to clofazimine", Tuberculosis, 115, pp.63~66 (2019)
- Wu H, "Indoleamine 2, 3-dioxygenase regulation of immune response(Review)", Mol. Med. Rep, 17, pp.4867~4873 (2018)
- Du Preez I, "Novel insights into the pharmacometabonomics of first-line tuberculosis drugs relating to metabolism, mechanism of action and drug-resistance", Drug Metab. Rev, 50, pp.466~481 (2018)
- Saini V, "Hydrogen sulfide stimulates Mycobacterium tuberculosis respiration, growth and pathogenesis", Nat. Commun, 11, pp.557~ (2020)
- Mahato S, "A putative cystathionine beta-synthase homolog of Mycobacterium smegmatis is involved in de novo cysteine biosynthesis", FASEB J, 34, pp.1~ (2020)
- A Guide to the Nagoya Protocol (ABS)for Researchers, "Chang YH", ABS Research Support Center, Korea Institute of Bioscience and Biotechnology(KRIBB), 93~ (2013)
- 허인, "나고야의정서 상의 유전자원의 접근 및 이익공유에 대한 EU의 이행 현황", 환경법연구, 39(1), pp.325~355 (2017), 한국환경법학회[DOI]
- 박원석, "나고야의정서와 식량농업용식물유전자원에 관한 국제조약과의 관계 - 농·식품분야 대응방안을 중심으로-", 중앙법학, 19(3), pp.33~66 (2017), 중앙법학회[DOI]
- Status of Access and Benefit-Sharing in 2015 (1), "Korea Biosafety Clearing House", 5~ (2016)
- The Act on Access to and Utilization of Genetic Resources and Benefit-Sharing (Law No. 14839), "Government of the Republic of Korea", ~ (2017)
- Trade Brief. No. 23, "Korea International Trade Association", 3~ (2017)
- Guidelines on Access to Genetic Resources and the Fair and Equitable Sharing of Benefits Arising from Their Utilization, "Ministry of the Environment, Government of Japan", ~ (2017)
- "EU ABS Regulation - REGULATION (EU) No 511", 2014 OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL of 16 April 2014 on compliance measures for users from the Nagoya Protocol on Access to Genetic Resources and the Fair and Equitable Sharing of Benefits Arising from their Utilization in the Union
- "Commission Implementing Regulation (EU) 2015", 1866 of 13October 2015 laying down detailed rules for the implementation of Regulation (EU) No 511 (2014), ~
- Federal Agency for Nature Conservation, Government of Germany, "Act Implementing the Obligations under the Nagoya Protocol and Transposing Regulation (EU) No. 511", 2014, 2016
- Guidance Document for the Implementation of Decree no. 59, "2017", ND-CP on the Management of Access to Genetic Resources and the Sharing of Benefits Arising from their Utilization, pp.2019, ~
- World Federation for Culture Collection, "Transparent Users-friendly System of Transfer (TRUST Handbook)", pp.2~ (2016)
- World Federation for Culture Collection, "Transparent Users-friendly System of Transfer(TRUST Guideline)", pp.1~ (2016)
- Chang YH, "Utilization of Genetic Resources and Associated Traditional Knowledge in Academic Research", pp.62~ (2017), ABS Research Support Center, Korea Institute of Bioscience and Biotechnology (KRIBB)
- Chang YH, "Agreement on Access and Benefit-sharing for Academic Research", pp.63~ (2018), ABS Research Support Center, Korea Institute of Bioscience and Biotechnology (KRIBB)
- 이종현, "해외 유전자원의 취득과 이용에 관한 ABS 체계의 이해와 연구자 대응방안", Journal of Plant Biotechnology, 48(1), pp.1~11 (2021), 한국식물생명공학회[DOI]